Skip to main content
. 2021 May 13;137(19):2585–2597. doi: 10.1182/blood.2020009471

Figure 2.

Figure 2.

Clinical outcomes: adjuvant arm. (A) Swimmer plots depicting outcomes after infusion of mLSTs in patients with AML/MDS who were in remission at the time of infusion. *Individuals who relapsed after HCT but were in morphological remission at the time of T-cell infusion. (B) Kaplan-Meier estimates of LFS in the adjuvant group.